SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-23-001729
Filing Date
2023-02-10
Accepted
2023-02-10 16:09:19
Documents
76
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K imra-10k_20221231.htm   iXBRL 10-K 2481004
2 EX-10.24 imra-ex1024_653.htm EX-10.24 21539
3 EX-23.1 imra-ex231_16.htm EX-23.1 7005
4 EX-31.1 imra-ex311_8.htm EX-31.1 22051
5 EX-31.2 imra-ex312_17.htm EX-31.2 23196
6 EX-32.1 imra-ex321_13.htm EX-32.1 10620
7 EX-32.2 imra-ex322_12.htm EX-32.2 11838
  Complete submission text file 0001564590-23-001729.txt   8586404

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA imra-20221231.xsd EX-101.SCH 57991
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imra-20221231_cal.xml EX-101.CAL 53593
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imra-20221231_def.xml EX-101.DEF 168626
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE imra-20221231_lab.xml EX-101.LAB 458192
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imra-20221231_pre.xml EX-101.PRE 345355
70 EXTRACTED XBRL INSTANCE DOCUMENT imra-10k_20221231_htm.xml XML 1391889
Mailing Address 1309 BEACON STREET SUITE 300 BROOKLINE MA 02446
Business Address 1309 BEACON STREET SUITE 300 BROOKLINE MA 02446 617-206-2020
IMARA Inc. (Filer) CIK: 0001672619 (see all company filings)

IRS No.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39247 | Film No.: 23611882
SIC: 2834 Pharmaceutical Preparations